Ginger

When moving from the observation of biological mechanisms to clinical applications in humans, ginger shows a particularly interesting profile, especially in the context of metabolic diseases. The picture that emerges from clinical studies is that of a substance capable of intervening at multiple levels simultaneously, not through a single, isolated action, but through an integrated modulation of glucose metabolism, lipid metabolism, and insulin resistance.

In patients with type 2 diabetes, for example, several randomized controlled trials have highlighted how ginger supplementation can significantly improve glycemic control. In one of these studies, conducted on diabetic subjects, the daily intake of ginger led to a reduction in fasting glycemia and HbA1c (a blood test that measures the average glucose concentration over the last 2-3 months), accompanied by an improvement in insulin sensitivity indices such as HOMA-IR (a parameter used to assess insulin sensitivity and diagnose insulin resistance). In practical terms, this means that the body's cells begin to "respond" better to insulin, reducing the need to maintain high levels in the blood (Mozaffari-Khosravi et al., 2014) [6].

A similar result also emerges in obese patients with recently diagnosed diabetes, where ginger supplementation for several weeks led to a simultaneous improvement in multiple parameters: a reduction in fasting glycemia, post-prandial glycemia, and HbA1c, as well as a significant decrease in circulating insulin and insulin resistance. In parallel, an improvement in the lipid profile was observed, with a reduction in total cholesterol, LDL, and triglycerides and an increase in HDL. It is as if ginger acts not on a single "gear," but on the entire metabolic system, bringing it back toward a more balanced condition (El Gayar et al., 2019) [7].

This systemic action becomes even more evident when analyzing subjects with metabolic syndrome, a condition characterized by the simultaneous presence of multiple alterations, including abdominal obesity, dyslipidemia, hypertension, and impaired glycemia. In a controlled clinical trial, supplementation with ginger led to a significant reduction in fasting glycemia, triglycerides, and insulin resistance, accompanied by improvements in blood pressure and anthropometric parameters such as body weight and waist circumference. In other words, ginger seems to act as a "global regulator" of metabolism, simultaneously influencing various cardiometabolic risk factors (Rahimlou et al., 2019) [8].

If we broaden our perspective further, including data from meta-analysis of randomized clinical trials, a coherent but also more nuanced picture emerges. Ginger supplementation is associated with a reduction in body weight, fasting glycemia, and the HOMA-IR index, as well as an increase in HDL cholesterol. However, some parameters, such as BMI or certain lipid fractions, do not always show significant changes. This suggests that the effect of ginger may be more pronounced on specific aspects of metabolism, such as fat distribution and insulin sensitivity, rather than on total body weight (Maharlouei et al., 2019) [9].

A particularly interesting area is that of non-alcoholic fatty liver disease, a condition closely linked to insulin resistance and lipid metabolism. In patients with type 2 diabetes, ginger supplementation has shown positive effects on various metabolic parameters, including the reduction of insulin and HOMA-IR and an increase in HDL. A significant reduction in blood pressure was observed, suggesting an effect on the cardiovascular system as well. However, no significant changes were detected in the structural parameters of the liver in the short term, indicating that the effect of ginger might manifest initially at a functional level rather than a structural one (Ghoreishi et al., 2024) [10].

Taken together, these results outline a clear interpretive model: ginger does not act as a drug "targeted" at a single goal, but as a multifactorial metabolic modulator. It is like intervening in a complex system by simultaneously adjusting multiple levers: glycemia, lipids, inflammation, and insulin sensitivity. This approach is particularly relevant in modern chronic diseases, which rarely depend on a single alteration.

In conclusion, the available clinical evidence indicates that ginger represents a promising nutraceutical support in the management of metabolic diseases, particularly diabetes, metabolic syndrome, and fatty liver disease. However, as with many compounds of natural origin, its role must be interpreted in a broader context that includes diet, lifestyle, and medical therapy, and not as a substitute for these interventions.

When analyzing the effects of ginger in the context of chronic diseases, a central element clearly emerges: its ability to intervene transversally on biological mechanisms shared by many modern diseases, particularly chronic inflammation, oxidative stress, and metabolic dysregulation. In this sense, ginger does not merely act on a single organ or a single pathology, but seems to fit into those “common biological nodes” that link seemingly different conditions.

A particularly relevant area is oncology, where ginger is studied as a chemopreventive agent—that is, to prevent, delay, or reverse the development of a disease, particularly cancer. Tumor transformation, in fact, is not a sudden event, but a progressive process that develops through cumulative DNA alterations, persistent inflammation, and uncontrolled proliferative signals. The bioactive compounds in ginger, such as gingerols and shogaols, appear to interfere with these processes on multiple levels: on one hand, they reduce the activation of pro-inflammatory pathways such as NF-κB, and on the other, they modulate proliferative and apoptotic signals, promoting the death of damaged cells. In other words, it is as if ginger intervenes both in the initial phases of tumor transformation and in the subsequent phases of growth and progression (Lechner and Stoner, 2019) [11].

This view is further reinforced by specific studies on colorectal cancer, where chronic intestinal inflammation represents one of the main risk factors. In this context, ginger shows a combination of effects particularly consistent with the pathophysiology of the disease: reduction of oxidative stress, modulation of the gut microbiota, protection of the intestinal barrier, and direct interference with the proliferation of tumor cells. Furthermore, it has been observed that its compounds can induce cell cycle arrest and activate apoptosis mechanisms, limiting tumor growth and metastatic spread. This set of actions suggests that ginger may act as a “regulator of the intestinal environment,” making it less favorable to tumor development and progression (Xiang et al., 2024) [12].

In parallel, ginger shows a significant role in chronic inflammatory diseases, which represent the common ground upon which many metabolic and degenerative conditions develop. Its bioactive compounds are capable of modulating some of the main inflammation signaling pathways, including NF-κB, by reducing the production of pro-inflammatory cytokines such as TNF-α, IL-6, and IL-1β. This effect has been observed in various clinical conditions, including rheumatoid arthritis, lupus, psoriasis, and inflammatory bowel diseases. In this context, ginger acts as a “biological shock absorber,” capable of attenuating excessive activation of the immune system without suppressing it completely (Ballester et al., 2022) [13].

In inflammatory bowel diseases, in particular, this action appears even more articulated. In addition to reducing inflammation, ginger intervenes at multiple levels of pathophysiology, also contributing to the maintenance of the integrity of the intestinal barrier. Furthermore, its ability to influence signaling pathways such as mTOR suggests a profound action on the cellular mechanisms that regulate growth, inflammation, and stress response. It is as if ginger does not just “turn off inflammation,” but works upstream, rebalancing the entire intestinal system (Lashgari et al., 2022) [14].

This ability to simultaneously modulate inflammation and metabolism also emerges in the context of type 2 diabetes and metabolic syndrome. Aggregate evidence shows that ginger is able to improve glycemic control, reduce HbA1c, and increase insulin sensitivity, with favorable effects also on the lipid profile. This suggests that the action of ginger is not limited to a direct hypoglycemic effect, but involves a broader regulation of the metabolic and inflammatory mechanisms that underlie these pathologies (Zhu et al., 2018) [15].

Overall, what emerges is an extremely consistent picture: ginger acts as a systemic modulator capable of intervening at multiple levels of human pathophysiology. This is not a specific and isolated action, but an integrated regulation of complex biological networks. This approach is particularly relevant in the context of modern chronic diseases, which do not derive from a single defect, but from a progressive and multifactorial dysfunction.

At the same time, it is essential to maintain a critical approach. Most of the strongest evidence comes from preclinical studies or clinical trials with limited samples and relatively short duration. This means that, although the results are promising, large-scale clinical application requires further confirmation, particularly to define optimal dosages, duration of interventions, and possible interactions with pharmacological therapies.

In summary, ginger is configured as one of the spices with the broadest spectrum of biological action among those studied, capable of connecting seemingly distinct areas—metabolism, inflammation, and oncology—through common mechanisms. It is precisely this “systems” view that makes its integration into advanced nutritional strategies particularly interesting.

One of the most interesting aspects of ginger concerns its ability to intervene directly in the main biological mechanisms underlying insulin resistance, a condition that represents the pathophysiological core of type 2 diabetes, non-alcoholic fatty liver disease, and metabolic syndrome. In the presence of insulin resistance, peripheral tissues become progressively less sensitive to insulin signaling, forcing the pancreas to maintain chronic compensatory hypersecretion of insulin. This state of persistent hyperinsulinemia fuels inflammation, oxidative stress, lipid accumulation, and continuous activation of the PI3K/AKT/mTOR pathway.

In this context, the main bioactive compounds of ginger, particularly gingerols and shogaols, appear to act as multifactorial metabolic modulators capable of simultaneously improving glucose homeostasis, inflammation, and cellular metabolic function. One of the most interesting clinical findings emerges from studies on gestational diabetes mellitus. In women with impaired glucose tolerance during pregnancy, six weeks of ginger supplementation resulted in a significant reduction in fasting glycemia, serum insulin, and HOMA index compared to the placebo (Hajimoosayi et al., 2020) [16]. This finding is particularly relevant because gestational diabetes is a condition strongly characterized by insulin resistance that is physiologically accentuated by pregnancy.

From a biological perspective, this suggests that ginger does not simply act by lowering glycemia, but rather improves the body's ability to respond correctly to insulin. It is as if the peripheral tissues progressively return to "recognizing" the insulin signal without requiring continuous compensatory pancreatic hypersecretion.

This relationship between ginger and insulin sensitivity emerges even more clearly in patients with type 2 diabetes. In a three-month randomized clinical trial, the daily intake of 3 grams of ginger led to significant reductions in fasting glycemia, HbA1c, circulating insulin, and HOMA-IR index (Shidfar et al., 2015) [17]. In parallel, the treated subjects showed an improvement in total antioxidant capacity and a reduction in two specific markers closely linked to oxidative stress and chronic inflammation.

This step is extremely important because it shows how insulin resistance, inflammation, and oxidative stress represent deeply intertwined processes. Excessive production of reactive oxygen species, in fact, alters insulin signaling and contributes to the maintenance of a chronic low-grade inflammatory state that makes the cellular response to insulin progressively inefficient. Ginger appears to break this vicious cycle by acting simultaneously on glucose metabolism and redox homeostasis (Shidfar et al., 2015) [17].

Even in diabetic patients undergoing hemodialysis, one of the most complex and inflammatory metabolic conditions, ginger supplementation showed favorable effects on glycemic control. In a randomized controlled clinical trial, treated patients showed a significant reduction in fasting glycemia and HOMA-IR index compared to the placebo group (Rostamkhani et al., 2023) [18].

This finding is particularly relevant because patients with end-stage renal disease and diabetes present with a condition of persistent chronic inflammation, severe oxidative stress, and marked alteration of insulin metabolism. The fact that ginger is able to improve insulin sensitivity even in such an advanced pathophysiological context further reinforces the biological plausibility of its metabolic effects (Rostamkhani et al., 2023) [18].

Further experimental evidence on the relationship between ginger and insulin resistance comes from a study conducted on rats fed a diet rich in fat and sucrose. In this model, the administration of 6-gingerol for ten weeks improved glycemia, insulin resistance, and lipid profile, while simultaneously reducing various indicators of inflammation and oxidative stress; these results suggest that 6-gingerol may act on multiple aspects of metabolic dysfunction associated with nutritional excess, linking the improvement of the insulin response to the containment of inflammation and oxidative damage (Essa and El-Metwally, 2026) [19].

The most robust evidence, however, emerges from the most recent "umbrella reviews" of clinical meta-analyses. A massive review comprising 296 randomized controlled trials and over 43,000 participants showed that ginger supplementation significantly improves fasting glycemia, HbA1c, HOMA-IR, and circulating insulin levels (Musazadeh et al., 2026) [20]. In parallel, consistent improvements in inflammatory markers and oxidative stress were observed.

Overall, the available evidence shows that ginger does not act simply as an aromatic spice or natural anti-inflammatory, but as a true modulator of metabolic physiology. Through gingerols and shogaols, this spice appears to improve insulin sensitivity, glucose metabolism, chronic inflammation, and oxidative stress, helping to reduce the metabolic load imposed by persistent hyperinsulinemia.

In this sense, the relationship between ginger and insulin resistance represents one of the most complete examples of how a natural compound can interact with the main biological nodes of modern metabolic diseases, offering physiologically coherent support within a broader strategy based on glycemic stability, the reduction of chronic inflammation, and the improvement of metabolic flexibility.

When delving into the heart of intracellular mechanisms, an aspect emerges that is particularly relevant for understanding the true potential of ginger: its ability to interact with one of the main regulatory pathways of cell growth and metabolism, namely the PI3K/AKT/mTOR axis. This pathway represents a sort of "control center" for the cell, capable of integrating energy, nutritional, and proliferative signals, determining whether the cell should grow, divide, or activate survival programs.

Within this context, one of the most studied compounds in ginger is 6-shogaol, which appears to exert a direct action on this very signaling network. In various tumor models, 6-shogaol has shown the ability to inhibit the activation of AKT, consequently reducing the downstream signal of mTOR. This effect translates into a reduction in cell proliferation and an increase in signals that lead to programmed cell death. In simple terms, it is as if the tumor cell were deprived of the signals that allow it to continue growing uncontrollably (Huang et al., 2021) [21].

This same mechanism has also been observed in other tumor models, such as cervical carcinoma, where 6-shogaol not only reduces the activation of the PI3K/AKT/mTOR pathway but also induces an increase in intracellular oxidative stress. The increase in reactive oxygen species acts as an upstream signal, contributing to the activation of apoptosis. At the same time, a phenomenon of autophagy has also been observed, which in some cases represents an attempt by the cell to survive the stress induced by the treatment. This creates a dynamic balance between cell death and adaptation, suggesting that the final effect depends on the specific biological context (Pei et al., 2021) [22].

A particularly interesting element is that this modulation of the PI3K/AKT/mTOR pathway does not exclusively concern tumor cells, but also extends to inflammatory and metabolic contexts. For example, in the intestinal barrier, 6-shogaol has demonstrated the ability to prevent damage induced by pro-inflammatory cytokines such as TNF-α, precisely through the inhibition of PI3K/AKT signaling. This results in the protection of cell junctions and a reduction in intestinal permeability, a crucial aspect in chronic inflammatory diseases. In this case, the pathway is not simply "turned off," but modulated in such a way as to restore a functional balance (Luettig et al., 2016) [23].

If we broaden our perspective further, it emerges that this action on the mTOR pathway represents one of the most important points of convergence for the biological effects of ginger. In gastrointestinal tumors, for example, the inhibition of the PI3K/AKT/mTOR cascade is associated not only with a reduction in cell proliferation but also with a decrease in the metabolic adaptation capacity of tumor cells, making them more vulnerable. This effect is accompanied by the modulation of other signaling pathways, such as NF-κB, creating a network of interference that simultaneously affects multiple aspects of tumor biology (Chen et al., 2023) [24].

Therefore, 6-shogaol seems to act as a true "multi-target" modulator, capable of interfering not only with mTOR but also with other signaling pathways known as NF-κB. This integrated action makes it possible to influence not only tumor growth but also the microenvironment in which the tumor develops, reducing inflammation, angiogenesis, and metastatic potential. It is as if the molecule does not limit itself to striking the tumor cell, but modifies the entire context that favors its survival (Figueroa-González et al., 2024) [25].

Overall, what emerges is an extremely coherent vision: ginger, through its main bioactive compounds, is able to modulate one of the central nodes of cellular physiology, integrating metabolic, inflammatory, and proliferative signals. This explains why its effects are not limited to a single area but extend to different diseases, which are, however, united by a dysregulation of these same pathways.

At the same time, it is important to emphasize that most of the evidence is derived from preclinical studies. This means that, although the mechanisms are becoming increasingly clear, their translation into the clinical setting requires further confirmation. However, the consistency of the data suggests that the interaction between ginger and the mTOR pathway represents one of the most promising aspects for understanding the nutritional and therapeutic role of this spice in the context of modern chronic diseases.

If the relationship between ginger and the PI3K/AKT/mTOR pathway already shows significant biological relevance, the picture becomes even more interesting when observing the role of AMPK, the primary cellular energy sensor. As discussed in the previous chapters, AMPK and mTOR represent two opposing yet complementary metabolic programs: when nutrients, glucose, and insulin are abundant, mTOR promotes cell growth, protein synthesis, and energy storage; conversely, when the cell perceives a state of energy stress or reduced ATP availability, AMPK slows down anabolic processes, reactivates autophagy, and promotes the restoration of metabolic homeostasis. In this delicate balance, the main bioactive compounds in ginger appear to act as potent modulators capable of restoring the proper dialogue between these two pathways.

One of the most interesting aspects emerges from studies on 6-gingerol in skeletal muscle cells. In mouse cell models, 6-gingerol significantly increased the phosphorylation of AMPKα2 (a specific variant), resulting in a clear increase in cellular glucose uptake. This effect was completely abolished by both the pharmacological inhibition of AMPK and the gene silencing of AMPKα2, confirming the central role of this kinase in the compound's mechanism of action.

From a biological standpoint, this finding is particularly relevant because it shows that 6-gingerol does not act simply by "improving glycemia," but intervenes directly on the cell's main energy sensor. The activation of AMPKα2 has, in fact, stimulated the cascade involving AS160 (a key protein in human metabolism, which regulates glucose), promoting the expression and translocation of GLUT4 toward the cell membrane (Lee et al., 2015) [26]. In other words, skeletal muscle becomes more efficient at absorbing glucose, reducing the load imposed on insulin and indirectly contributing to limiting the chronic hyperactivation of mTOR.

Also particularly interesting is the involvement of the protein phosphatase PP2A (a fundamental enzyme in human cells that acts as a tumor suppressor). 6-gingerol significantly reduced the activity of PP2A, thereby facilitating the phosphorylation of AMPKα2. This suggests a sophisticated regulatory mechanism through which ginger does not merely "activate" AMPK, but promotes its functional stabilization.

The relationship between AMPK and inflammation emerges with even greater clarity in animal models fed a high-fat diet. In HFD rats, 6-gingerol significantly increased the phosphorylated form of AMPK-α1, while simultaneously reducing the expression of NF-κB, one of the main regulators of chronic inflammation (Hashem et al., 2017) [27]. This effect was associated with an increase in the expression of SIRT-6 and a reduction in resistin, an adipokine strongly involved in insulin resistance.

From a pathophysiological perspective, this step is extremely important because it shows how AMPK regulates not only energy metabolism but also the systemic inflammatory response. When AMPK is reduced, as frequently occurs in obesity and chronic hyperinsulinemia, NF-κB remains constantly active, promoting the production of TNF-α, metabolic inflammation, and progressive alteration of insulin signaling. 6-gingerol, on the other hand, appears to interrupt this pathological circuit, fostering a more stable and less inflammatory metabolic environment (Hashem et al., 2017) [27].

The treated animals, in fact, showed a significant reduction in TNF-α, free fatty acids, and inflammatory markers, accompanied by an improvement in glycemia and a reduction in visceral fat accumulation. It is as if the activation of AMPK by ginger helps the body to progressively exit a state of "permanent metabolic alarm."

An additional level of complexity emerges from studies on non-alcoholic fatty liver disease. In HFD mouse models and cells treated with palmitic acid, 6-gingerol reduced steatosis, inflammation, and oxidative stress through the activation of the LKB1/AMPK pathway (Liu et al., 2023) [28].

The activation of AMPK was accompanied by a reduction in the expression of fundamental components of the metabolic network involved in fat synthesis and an increase in closely related proteins that work in synergy to regulate cellular energy metabolism. In biological terms, this means that the liver is progressively shifted from a mode of lipogenesis and accumulation toward a mode of lipid oxidation and greater energy efficiency.

The relationship between ginger, AMPK, and mitochondrial function emerges even more clearly in models of muscle aging. In elderly rats treated with 6-gingerol, a significant reduction in ectopic lipid accumulation was observed, accompanied by an improvement in mitochondrial function and a reduction in the HOMA-IR index (Liu et al., 2019) [29]. Parallel to this, the treatment increased adiponectin (a hormone produced by adipose tissue that improves insulin sensitivity) and AMPK phosphorylation.

This aspect is extremely important because it links AMPK activation to mitochondrial biogenesis (the process through which cells produce new mitochondria) and metabolic flexibility. Through the adiponectin/AMPK axis, 6-gingerol appears to improve the muscle's ability to oxidize fatty acids and use energy more efficiently. It is as if ginger helps "metabolically aged" muscle recover part of its original energy capacity.

Even the most recent studies on adipocytes confirm this picture. A mixture of gingerols and shogaols significantly increased mitochondrial density, ATP-linked respiration, and maximum respiratory capacity in differentiated adipocytes, simultaneously promoting the activation of AMPK (Preciado-Ortiz et al., 2025) [30]. Concurrently, a reduction in intracellular lipid droplets and an increase in lipolysis were observed.

Overall, the available evidence outlines ginger as one of the most sophisticated natural modulators of the AMPK–mTOR axis. Through the activation of AMPK and the indirect reduction of the pathological hyperactivation of mTOR, its bioactive compounds appear to promote autophagy, lipid oxidation, mitochondrial biogenesis, energy flexibility, and improved insulin sensitivity.

In a context characterized by chronic hyperinsulinemia, nutritional excess, and continuous anabolic stimulation, the relationship between ginger, AMPK, and mTOR therefore takes on a meaning deeply consistent with what was discussed in the previous chapters: helping the cell exit a mode of forced and metabolically dysfunctional growth, returning it toward a condition of greater energy balance, adaptation, and metabolic resilience.